These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 33485815)
1. Factors associated with opioid-tapering success: A mixed methods study. Kuntz JL; Dickerson JF; Schneider JL; Firemark AJ; Papajorgji-Taylor D; Slaughter M; Reese KR; Thorsness LA; Sullivan MD; Debar LL; Smith DH J Am Pharm Assoc (2003); 2021; 61(3):248-257.e1. PubMed ID: 33485815 [TBL] [Abstract][Full Text] [Related]
2. "I really had somebody in my corner." Patient experiences with a pharmacist-led opioid tapering program. Schneider JL; Firemark AJ; Papajorgji-Taylor D; Reese KR; Thorsness LA; Sullivan MD; DeBar LL; Smith DH; Kuntz JL J Am Pharm Assoc (2003); 2023; 63(1):241-251.e1. PubMed ID: 35718714 [TBL] [Abstract][Full Text] [Related]
3. "I'm Not Gonna Pull the Rug out From Under You": Patient-Provider Communication About Opioid Tapering. Matthias MS; Johnson NL; Shields CG; Bair MJ; MacKie P; Huffman M; Alexander SC J Pain; 2017 Nov; 18(11):1365-1373. PubMed ID: 28690000 [TBL] [Abstract][Full Text] [Related]
4. A Pharmacist-Led Program to Taper Opioid Use at Kaiser Permanente Northwest: Rationale, Design, and Evaluation. Kuntz JL; Schneider JL; Firemark AJ; Dickerson JF; Papajorgji-Taylor D; Reese KR; Hamer TA; Marsh D; Thorsness LA; Sullivan MD; Debar LL; Smith DH Perm J; 2020; 24():. PubMed ID: 33196429 [TBL] [Abstract][Full Text] [Related]
5. "We Need to Taper." Interviews with Clinicians and Pharmacists About Use of a Pharmacy-Led Opioid Tapering Program. Firemark AJ; Schneider JL; Kuntz JL; Papajorgji-Taylor D; Dickerson JF; Thorsness LA; Reese KR; Sullivan MD; Debar LL; Smith DH Pain Med; 2021 May; 22(5):1213-1222. PubMed ID: 33616160 [TBL] [Abstract][Full Text] [Related]
6. A Survey on Opioid Tapering Practices, Policies, and Perspectives by Pain and Palliative Care Pharmacists. Kral LA; Bettinger JJ; Vartan CM; Hadlandsmyth K; Kullgren J; Smith MA J Pain Palliat Care Pharmacother; 2022 Mar; 36(1):2-10. PubMed ID: 35254209 [TBL] [Abstract][Full Text] [Related]
7. Opioid tapering after surgery: a qualitative study of patients' experiences. Uhrbrand P; Phillipsen A; Dreyer P; Nikolajsen L Scand J Pain; 2020 Jul; 20(3):555-563. PubMed ID: 32338635 [TBL] [Abstract][Full Text] [Related]
8. Patients' Perspectives on Tapering of Chronic Opioid Therapy: A Qualitative Study. Frank JW; Levy C; Matlock DD; Calcaterra SL; Mueller SR; Koester S; Binswanger IA Pain Med; 2016 Oct; 17(10):1838-1847. PubMed ID: 27207301 [TBL] [Abstract][Full Text] [Related]
9. Recent tapering from long-term opioid therapy and odds of opioid-related hospital use. Mazurenko O; Blackburn J; Zhang P; Gupta S; Harle CA; Kroenke K; Simon K Pharmacoepidemiol Drug Saf; 2023 May; 32(5):526-534. PubMed ID: 36479785 [TBL] [Abstract][Full Text] [Related]
10. Patient Perspectives on Improving Patient-Provider Relationships and Provider Communication During Opioid Tapering. Kosakowski S; Benintendi A; Lagisetty P; Larochelle MR; Bohnert ASB; Bazzi AR J Gen Intern Med; 2022 May; 37(7):1722-1728. PubMed ID: 34993861 [TBL] [Abstract][Full Text] [Related]
11. Assessment of outcomes following high-dose opioid tapering in a Veterans Healthcare System. Hundley L; Spradley S; Donelenko S J Opioid Manag; 2018; 14(2):89-101. PubMed ID: 29733095 [TBL] [Abstract][Full Text] [Related]
12. Opioid tapering in patients with prescription opioid use disorder: A retrospective study. Zhou K; Jia P; Bhargava S; Zhang Y; Reza T; Peng YB; Wang GG Scand J Pain; 2017 Oct; 17():167-173. PubMed ID: 28988103 [TBL] [Abstract][Full Text] [Related]
13. A physician-pharmacist collaborative care model to prevent opioid misuse. Lagisetty P; Smith A; Antoku D; Winter S; Smith M; Jannausch M; Mi Choe H; Bohnert ASB; Heisler M Am J Health Syst Pharm; 2020 May; 77(10):771-780. PubMed ID: 32315401 [TBL] [Abstract][Full Text] [Related]
14. Patient Engagement Survey Regarding Future Double-Blinded, Randomized Controlled Trial of Tapering of Chronic Opioid Therapy. James J; Lai B; Witt T J Prim Care Community Health; 2019; 10():2150132719890231. PubMed ID: 31777325 [No Abstract] [Full Text] [Related]
15. Opioid medication discontinuation and risk of adverse opioid-related health care events. Mark TL; Parish W J Subst Abuse Treat; 2019 Aug; 103():58-63. PubMed ID: 31079950 [TBL] [Abstract][Full Text] [Related]
16. How prepared are pharmacists to provide over-the-counter naloxone? The role of previous education and new training opportunities. Lai Joyce Chun K; Olsen A; Taing MW; Clavarino A; Hollingworth S; Dwyer R; Middleton M; Nielsen S Res Social Adm Pharm; 2019 Aug; 15(8):1014-1020. PubMed ID: 30926251 [TBL] [Abstract][Full Text] [Related]
17. Using role theory to explore pharmacist role conflict in opioid risks communication. Thakur T; Chewning B Res Social Adm Pharm; 2020 Aug; 16(8):1121-1126. PubMed ID: 31767475 [TBL] [Abstract][Full Text] [Related]
18. Long-term opioid therapy tapering: Trends from 2014 to 2018 in a Midwestern State. Mazurenko O; Gupta S; Blackburn J; Simon K; Harle CA Drug Alcohol Depend; 2021 Nov; 228():109108. PubMed ID: 34688106 [TBL] [Abstract][Full Text] [Related]
19. Medical Record Documentation About Opioid Tapering: Examining Benefit-to-Harm Framework and Patient Engagement. Buonora M; Perez HR; Stumph J; Allen R; Nahvi S; Cunningham CO; Merlin JS; Starrels JL Pain Med; 2020 Oct; 21(10):2574-2582. PubMed ID: 32142143 [TBL] [Abstract][Full Text] [Related]
20. Team-Based Medicine: Incorporating a Clinical Pharmacist into Pain and Opioid Practice Management. Boren LL; Locke AM; Friedman AS; Blackmore CC; Woolf R PM R; 2019 Nov; 11(11):1170-1177. PubMed ID: 30729723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]